Market revenue in 2023 | USD 272.2 million |
Market revenue in 2030 | USD 614.1 million |
Growth rate | 12.3% (CAGR from 2023 to 2030) |
Largest segment | Blood sample |
Fastest growing segment | Blood Sample |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Blood Sample |
Key market players worldwide | ANGLE PLC, Guardant Health Inc, Myriad Genetics Inc, Biocept Inc, Lucence Health, Roche, Qiagen NV, Illumina Inc, Thermo Fisher Scientific Inc, Epigenomics AG, Oncimmune, Freenome |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to liquid biopsy market will help companies and investors design strategic landscapes.
Blood sample was the largest segment with a revenue share of 73.25% in 2023. Horizon Databook has segmented the Latin America liquid biopsy market based on blood sample covering the revenue growth of each sub-segment from 2018 to 2030.
The Latin America liquid biopsy market has exhibited significant growth in the past few years owing to increased prevalence of various types of cancer in the region. Several surveys by various government and nonprofit organizations revealed that overall cancer mortality in Latin America is almost twice that of high-income countries.
However, poor infrastructure combined with inaccessibility to remote regions, low affordability, and shortage of skilled professionals may hamper market growth in this region during the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America liquid biopsy market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America liquid biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account